124703-78-2 Usage
General Description
4(1H)-Pyrimidinone, 6-ethyl- (9CI) is a chemical compound with the molecular formula C6H8N2O. It is a derivative of pyrimidine, a heterocyclic organic compound. 4(1H)-Pyrimidinone, 6-ethyl- (9CI) is commonly used as a building block in the synthesis of pharmaceutical compounds and agrochemicals. It has also been studied for its potential biological activities, including anti-inflammatory and antimicrobial properties. 4(1H)-Pyrimidinone, 6-ethyl- (9CI) may also be used in various industrial applications, such as in the production of polymers and other organic compounds. Overall, this chemical compound has a wide range of potential uses and applications in the fields of chemistry, pharmaceuticals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 124703-78-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,7,0 and 3 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 124703-78:
(8*1)+(7*2)+(6*4)+(5*7)+(4*0)+(3*3)+(2*7)+(1*8)=112
112 % 10 = 2
So 124703-78-2 is a valid CAS Registry Number.
124703-78-2Relevant articles and documents
Synthesis method of voriconazole impurity B
-
Paragraph 0026-0027, (2019/10/23)
The invention relates to a synthesis method of a voriconazole impurity B. The synthesis method of the voriconazole impurity B comprises the steps of firstly, dissolving formamidine acetate and sodiumtert-butoxide in methyl alcohol, conducting stirring und
TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF
-
Paragraph 00183, (2018/04/11)
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R6, R7 and R8 are as defined herein.
NEW 5-ALKYNYL-PYRIDINES
-
Paragraph 0209; 0210, (2013/03/26)
5-alkynyl-pyridine of general formula (I) which are inhibitors of the activity of PI3K alpha, and their use in the treatment of diseases characterized by excessive or abnormal cell proliferation, such as cancer.
